Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00982657
What this trial is testing

A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Solid Tumor
Pfizer 34
Testing effectiveness (Phase 2)Study completedNCT00667394
What this trial is testing

Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00005647
What this trial is testing

SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00023738
What this trial is testing

Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Radiation Therapy Oncology Group
Not applicableStudy completedNCT01819597
What this trial is testing

Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis

Who this might be right for
Intracranial Arterial StenosisIntracranial AtherosclerosisIschemic Stroke+1 more
Cedars-Sinai Medical Center 52
Not applicableStudy completedNCT00671242
What this trial is testing

Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake

Who this might be right for
AngiogenesisNon-Small Cell Lung Cancer
Gunma University
Not applicableStudy completedNCT06396403
What this trial is testing

The Role of Red Cell Characteristics, Angiogenesis, Viscosity and Oxygenation in the Pathophysiology of Sickle Cell Related Retinopathy

Who this might be right for
Sickle Cell RetinopathySickle Cell DiseaseSickle Cell SC Disease+1 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 68
Testing effectiveness (Phase 2)Study completedNCT00089609
What this trial is testing

Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasms
National Cancer Institute (NCI) 73
Not applicableLooking for participantsNCT07222683
What this trial is testing

The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseKidney TransplantCoronary Microvascular Dysfunction (CMD)+1 more
Brigham and Women's Hospital 80
Early research (Phase 1)Study completedNCT00644124
What this trial is testing

Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
Sanofi 25
Early research (Phase 1)Study completedNCT01468922
What this trial is testing

Pazopanib and ARQ 197 for Advanced Solid Tumors

Who this might be right for
Solid Tumor
National Cancer Institute (NCI) 32
Early research (Phase 1)Study completedNCT00395434
What this trial is testing

Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Mateon Therapeutics 20
Testing effectiveness (Phase 2)Study completedNCT00851045
What this trial is testing

Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer (CRC)
Bristol-Myers Squibb 17
Testing effectiveness (Phase 2)UnknownNCT04556071
What this trial is testing

Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsFallopian Tube NeoplasmsEndocrine Gland Neoplasms+21 more
Xiaoxiang Chen 32
Not applicableUnknownNCT01229670
What this trial is testing

Effects of Aerobic Interval and Continuous Exercise Trainings in Patients With Chronic Heart Failure

Who this might be right for
Cardiac and Hemodynamic ResponseBlood Flow Distribution and Oxygen Uptake EfficiencyHemorheology Modulated by Erythrocyte+2 more
Chang Gung Memorial Hospital 90
Testing effectiveness (Phase 2)Study completedNCT01006369
What this trial is testing

Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Rutgers, The State University of New Jersey 38
Testing effectiveness (Phase 2)Ended earlyNCT01712685
What this trial is testing

Imaging Studies of Kidney Cancer Using 18F-VM4-037

Who this might be right for
Carcinoma, Renal CellKidney Neoplasms
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT03801447
What this trial is testing

Biomarkers and Preeclampsia Outcomes

Who this might be right for
Preeclampsia
Dacima Consulting 600
Testing effectiveness (Phase 2)UnknownNCT00956332
What this trial is testing

Safety Study of MultiGeneAngio in Patients With Chronic Critical Limb Ischemia

Who this might be right for
Peripheral Arterial DiseasePeripheral Vascular DiseaseCritical Limb Ischemia
MultiGene Vascular Systems Ltd. 28
Early research (Phase 1)Ended earlyNCT00520533
What this trial is testing

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)
Ludwig Institute for Cancer Research 8
Next Page